Some adverse effects of antipsychotics: Prevention and treatment

Journal of Clinical Psychiatry

Volumn 60, Issue SUPPL. 12, 1999, Pages 18-21

  Lader, Malcolm ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CLOZAPINE; NEUROLEPTIC AGENT; OLANZAPINE; PHENOTHIAZINE DERIVATIVE; PIMOZIDE; PROPRANOLOL; REMOXIPRIDE; SERTINDOLE; THIORIDAZINE; ZIPRASIDONE;

ANTICHOLINERGIC EFFECT; APLASTIC ANEMIA; CARDIOTOXICITY; DRUG MONITORING; EXTRAPYRAMIDAL SYMPTOM; HUMAN; HYPERPROLACTINEMIA; HYPOTENSION; NEUROLEPTIC MALIGNANT SYNDROME; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL; REVIEW; SCHIZOPHRENIA; SEIZURE; SUDDEN DEATH; WEIGHT GAIN;

ANTIPSYCHOTIC AGENTS; BASAL GANGLIA DISEASES; DYSKINESIA, DRUG-INDUCED; HUMANS; HYPERPROLACTINEMIA; HYPOTENSION; PATIENT EDUCATION; PRACTICE GUIDELINES; SCHIZOPHRENIA; SEIZURES; WEIGHT GAIN;

EID: 0033045961     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (34)

1. Hansen TE, Casey DE, Hoffman WF. Neuroleptic intolerance. Schizophr Bull 1997;23:567-582
2. Fleischhacker WW Meise U, Gunther V, et al. Compliance with antipsychotic drug treatment: influence of side effects. Acta Psychiatr Scand Suppl 1994;382:11-15
3. Umbricht D, Kane JM. Medical complications of new antipsychotic drugs. Schizophr Bull 1996;22:475-483
4. Casey DE. The relationship of pharmacology to side effects. J Clin Psychiatry 1997;58(suppl 10):55-62
5. Gelenberg A. Sexual functioning, antipsychotic drugs and plasma protein. Biol Ther Psychiatry 1982;5:18
6. Gitlin MJ. Psychotropic medications and their effects on sexual function: diagnosis, biology, and treatment approaches. J Clin Psychiatry 1994; 55:406-413
7. Windgassen K, Wesselmann U, Schulze Monking H. Galactorrhea and hyperprolactinemia in schizophrenic patients on neuroleptics: frequency and etiology. Neuropsychobiology 1996;33:142-146
8. Meltzer HY. Clinical studies on the mechanism of action of clozapine: the dopamine-serotonin hypotheses of schizophrenia. Psychopharmacology (Berl) 1989;99:S18-S27
9. Devinsky O, Honigfeld G, Patin J. Clozapine-related seizures. Neurology 1991;41:369-371
10. Toth P, Frankenburg FR. Clozapine and seizures: a review. Can J Psychiatry 1994;39:236-238
11. Burggraf GW. Are psychotropic drugs at therapeutic levels a concern for cardiologists? Can J Cardiol 1997;13:75-80
12. Marinkovic D, Timotijevic I, Babinski T, et al. The side-effects of clozapine: a four-year follow-up study. Prog Neuropsychopharmacol Biol Psychiatry 1994;18:537-544
13. Peacock L, Solgaard T, Lublin H, et al. Clozapine versus typical antipsychotics: a retro-and prospective study of extrapyramidal side effects. Psychopharmacology (Berl) 1996;124:188-196
14. Miller CH, Mohr F, Umbricht D, et al. The prevalence of acute extrapyramidal signs and symptoms in patients treated with clozapine, risperidone, and conventional antipsychotics. J Clin Psychiatry 1998;59:69-75
15. Love RC. Novel versus conventional antipsychotic drugs. Pharmacotherapy 1996;16 6-10
16. Kopala LC. Spontaneous and drug-induced movement disorders in schizophrenia. Acta Psychiatr Scand Suppl 1996;389:12-17
17. Malhotra AK, Litman RE, Pickar D. Adverse effects of antipsychotic drugs. Drug Saf 1993;9:429-436
18. Dalack GW, Becks L, Meador-Woodruff JH. Tardive dyskinesia, clozapine, and treatment response. Prog Neuropsychopharmacol Biol Psychiatry 1998;22:567-573
19. Casey DE. Effects of clozapine therapy in schizophrenic individuals at risk for tardive dyskinesia. J Clin Psychiatry 1998;59 (suppl 3):31-37
20. Warner JP, Barnes TR, Henry JA. Electrocardiographic changes in patients receiving neuroleptic medication. Acta Psychiatr Scand 1996;93:311-313
21. Mehtonen OP, Aranko K, Malkonen L, et al. A survey of sudden death associated with the use of antipsychotic or antidepressant drugs: 49 cases in Finland. Acta Psychiatr Scand 1991;84:58-64
22. Buckley NA, Whyte IM, Dawson AH. Cardiotoxicity more common in thioridazine overdose than with other neuroleptics. J Toxicol Clin Toxicol 1995;13:199-204
23. Krahenbuhl S, Sauter B, Kupferschmidt H, et al. Case report: reversible QT prolongation with torsades de pointes in a patient with pimozide intoxication. Am J Med Sci 1995;309:315-316
24. Brown RP, Kocsis JH. Sudden death and antipsychotic drugs. Hosp Community Psychiatry 1984;35:486-491
25. Jusic N, Lader M. Post-mortem antipsychotic drug concentrations and unexplained deaths. Br J Psychiatry 1994;165:787-791
26. Tueth MJ. Emergencies caused by side effects of psychiatric medications. Am J Emerg Med 1994;12:212-216
27. Ravin DS, Levenson JW. Fatal cardiac event following initiation of risperidone therapy. Ann Pharmacother 1997;31:867-870
28. Kumar A. Sudden unexplained death in a psychiatric patient - a case report: the role of phenothiazines and physical restraint. Med Sci Law 1997; 37:170-175
29. Naganuma H, Fujii I. Incidence and risk factors in neuroleptic malignant syndrome. Acta Psychiatr Scand 1994;90:424-426
30. Marcus J, Mulvihill FJ. Agranulocytosis and chlorpromazine. J Clin Psychiatry 1978;39:784-786
31. Alphs LD, Anand R. Clozapine: the commitment to patient safety. J Clin Psychiatry 1999;60(suppl 12):39-42
32. Philpott NJ, Marsh JC, Gordon-Smith EC, et al. Aplastic anaemia and remoxipride [letter]. Lancet 1993;342:1244-1245
33. Laidlaw ST, Snowden JA, Brown MJ. Aplastic anaemia and remoxipride [letter). Lancet 1993;342:1245
34. Watson RGP, Olomu A, Clements D, et al. A proposed mechanism for chlorpromazine jaundice defective hepatic sulphoxidation combined with rapid hydroxylation. J Hepatol 1988;7:72-78